H.R. 5382 · 116th Congress
To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.
- Stage
- In committee
- Sponsor
- Jeff Fortenberry
- Introduced
- 2019-12-10
- Latest action
- 2019-12-11 · Referred to the Subcommittee on Health.
Subjects
Health care coverage and access
Health
Prescription drugs
Retail and wholesale trades